Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 3
2007 3
2008 3
2009 2
2010 3
2011 4
2012 5
2013 2
2014 4
2015 3
2016 6
2017 2
2018 4
2019 14
2020 12
2021 9
2022 12
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
PARP Inhibitors in Ovarian Cancer.
Mittica G, Ghisoni E, Giannone G, Genta S, Aglietta M, Sapino A, Valabrega G. Mittica G, et al. Among authors: valabrega g. Recent Pat Anticancer Drug Discov. 2018;13(4):392-410. doi: 10.2174/1574892813666180305165256. Recent Pat Anticancer Drug Discov. 2018. PMID: 29512470 Free article. Review.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. Among authors: valabrega g. N Engl J Med. 2023 Mar 27. doi: 10.1056/NEJMoa2216334. Online ahead of print. N Engl J Med. 2023. PMID: 36972026
Immunotherapy in cervix cancer.
Attademo L, Tuninetti V, Pisano C, Cecere SC, Di Napoli M, Tambaro R, Valabrega G, Musacchio L, Setola SV, Piccirillo P, Califano D, Spina A, Losito S, Greggi S, Pignata S. Attademo L, et al. Among authors: valabrega g. Cancer Treat Rev. 2020 Nov;90:102088. doi: 10.1016/j.ctrv.2020.102088. Epub 2020 Aug 7. Cancer Treat Rev. 2020. PMID: 32827839 Review.
Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
Turinetto M, Valsecchi AA, Tuninetti V, Scotto G, Borella F, Valabrega G. Turinetto M, et al. Among authors: valabrega g. Int J Mol Sci. 2022 Mar 24;23(7):3559. doi: 10.3390/ijms23073559. Int J Mol Sci. 2022. PMID: 35408919 Free PMC article. Review.
Translational Research in Ovarian Cancer.
Di Renzo MF, Valabrega G. Di Renzo MF, et al. Among authors: valabrega g. Cancers (Basel). 2020 Dec 8;12(12):3676. doi: 10.3390/cancers12123676. Cancers (Basel). 2020. PMID: 33302341 Free PMC article.
Is there a role for immunotherapy in ovarian cancer?
Giannone G, Valabrega G. Giannone G, et al. Among authors: valabrega g. Ann Transl Med. 2019 Dec;7(Suppl 8):S276. doi: 10.21037/atm.2019.12.13. Ann Transl Med. 2019. PMID: 32015995 Free PMC article. No abstract available.
97 results